Lentigen Corporation is extensively collaborating with academic, government and selected companies to develop its LentiMax™ technology broadly in biotechnology and biomedicine. Areas of collaboration include genomic research, drug discovery, target validation, animal models, biogenerics, vaccines and gene therapies.

• University of Pennsylvania
• US Army, Edgewood Chemical Biological Center
• Children's Hospital of Philadelphia
• Johns Hopkins School of Medicine
• Case Western Reserve University
• National Cancer Institute
• University of Chicago
• University of Maryland
• Dharmacon/Fisher
• Wave Biotechnologies
• University of Georgia
• University of California
• Scripps Research Institute
• Stanford University
• Omnia Biologics